Follow
Joseph Proietto
Joseph Proietto
Professor of Medicine University of Melbourne
Verified email at unimelb.edu.au
Title
Cited by
Cited by
Year
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
22902019
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
22342006
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial
JB Dixon, PE O’Brien, J Playfair, L Chapman, LM Schachter, S Skinner, ...
Jama 299 (3), 316-323, 2008
19192008
Long-term persistence of hormonal adaptations to weight loss
P Sumithran, LA Prendergast, E Delbridge, K Purcell, A Shulkes, ...
New England Journal of Medicine 365 (17), 1597-1604, 2011
17292011
Evaluating the glucose tolerance test in mice
S Andrikopoulos, AR Blair, N Deluca, BC Fam, J Proietto
American Journal of Physiology-Endocrinology and Metabolism 295 (6), E1323-E1332, 2008
8872008
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
MEE Jones, AW Thorburn, KL Britt, KN Hewitt, NG Wreford, J Proietto, ...
Proceedings of the National Academy of Sciences 97 (23), 12735-12740, 2000
8722000
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
CW Le Roux, A Astrup, K Fujioka, F Greenway, DCW Lau, L Van Gaal, ...
The Lancet 389 (10077), 1399-1409, 2017
7172017
Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial
PE O'Brien, JB Dixon, C Laurie, S Skinner, J Proietto, J McNeil, B Strauss, ...
Annals of internal medicine 144 (9), 625-633, 2006
6682006
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 131-138, 2019
5362019
Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling
GR Steinberg, BJ Michell, BJW van Denderen, MJ Watt, AL Carey, ...
Cell metabolism 4 (6), 465-474, 2006
5232006
Ketosis and appetite-mediating nutrients and hormones after weight loss
P Sumithran, LA Prendergast, E Delbridge, K Purcell, A Shulkes, ...
European journal of clinical nutrition 67 (7), 759-764, 2013
3942013
The defence of body weight: a physiological basis for weight regain after weight loss
P Sumithran, J Proietto
Clinical Science 124 (4), 231-241, 2013
3752013
Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes
CE Hagberg, A Mehlem, A Falkevall, L Muhl, BC Fam, H Ortsäter, ...
Nature 490 (7420), 426-430, 2012
3132012
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised …
P Dandona, C Mathieu, M Phillip, L Hansen, SC Griffen, D Tschöpe, ...
The lancet Diabetes & endocrinology 5 (11), 864-876, 2017
3042017
Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y
DA Ainslie, MJ Morris, G Wittert, H Turnbull, J Proietto, AW Thorburn
International journal of obesity 25 (11), 1680-1688, 2001
2962001
The effect of rate of weight loss on long-term weight management: a randomised controlled trial
K Purcell, P Sumithran, LA Prendergast, CJ Bouniu, E Delbridge, ...
The Lancet Diabetes & Endocrinology 2 (12), 954-962, 2014
2572014
Pharmacotherapy for obesity
LL Ioannides-Demos, J Proietto, JJ McNeil
Drugs 65, 1391-1418, 2005
2512005
Carbohydrate fermentation decreases hepatic glucose output in healthy subjects
A Thorburn, J Muir, J Proietto
Metabolism 42 (6), 780-785, 1993
2411993
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study
P Dandona, C Mathieu, M Phillip, L Hansen, D Tschöpe, F Thorén, J Xu, ...
Diabetes Care 41 (12), 2552-2559, 2018
2242018
Influence of muscle glycogen on glycogenolysis and glucose uptake during exercise in humans
M Hargreaves, G McConell, J Proietto
Journal of Applied Physiology 78 (1), 288-292, 1995
2231995
The system can't perform the operation now. Try again later.
Articles 1–20